Hexarelin: A Hormone Response Is Not a Health Outcome
AXON Research Institute • AXON Peptide affiliation
Educational draft • Scientific + legal review pending
Silent film with full on-screen captions. Conceptual illustrations, not molecular structures.

Hexarelin is a synthetic growth-hormone-releasing peptide. Human experiments ask how hormone levels respond, which is a different question from whether a person becomes healthier or stronger. A double-blind, placebo-controlled study found that Hexarelin stimulated growth-hormone release in healthy volunteers. The researchers measured an endocrine response, not lasting muscle gains. Other human research also examined effects on prolactin, ACTH and cortisol. This reminds us that hormonal interventions can involve more than one signalling system. Short-term hormone measurements do not settle long-term benefit or safety. Claims about recovery, body composition or anti-aging need trials designed to measure those outcomes directly.

END CARD
Educational draft. Not medical advice. Sources and limitations accompany this film.

SOURCES
[1] Growth hormone-releasing activity of hexarelin in humans: A dose-response study (1994)
https://pubmed.ncbi.nlm.nih.gov/7957536/
Primary double-blind placebo-controlled human study; indexed abstract reviewed

[2] Korbonits et al. (1995): The effect of an opiate antagonist on the hormonal changes induced by hexarelin
https://pubmed.ncbi.nlm.nih.gov/7586608/
Primary randomized human endocrine experiment; abstract reviewed

EVIDENCE LIMITATIONS
Do not equate a GH pulse with muscle gain, improved recovery or longevity.
Acute volunteer studies do not establish safety with long-term or unsupervised use.
The script reports measured endocrine research without prescribing or extrapolating treatment protocols.

TOPIC INVENTORY PROVENANCE (not reused audiovisual media)
Original topic requested by Nina; not attributed to an additional verified Facebook video.